| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abnormalities of primary hemostasis in patients with liver cirrhosis
|
Leo, R.
|
|
1993
|
70 |
S1 |
p. S41-
1 p.
|
artikel
|
| 2 |
A case of factor V (FV) acquired inhibitor
|
|
|
1993
|
70 |
S1 |
p. S121-
1 p.
|
artikel
|
| 3 |
Acidosis and not sympathetic activation induces fibrynolitic activation during physical exercise
|
|
|
1993
|
70 |
S1 |
p. S88-
1 p.
|
artikel
|
| 4 |
A comparative study on the quality of oral anticoagulant therapy (warfarin vs acenocoumarol)
|
|
|
1993
|
70 |
S1 |
p. S24-
1 p.
|
artikel
|
| 5 |
Acquired factor VIII inhibitor unresponsive to administration of high-dose immunoglobulins
|
|
|
1993
|
70 |
S1 |
p. S35-
1 p.
|
artikel
|
| 6 |
Acquired haemophilia A: Our experience on clinical manifestations and outcomes of nine patients
|
|
|
1993
|
70 |
S1 |
p. S34-
1 p.
|
artikel
|
| 7 |
Acquired risk factors for deep vein thrombosis (DVT) in the outpatient population
|
|
|
1993
|
70 |
S1 |
p. S130-
1 p.
|
artikel
|
| 8 |
Activation of phagocytes in unstable angina role in hemostasis and inflammation
|
|
|
1993
|
70 |
S1 |
p. S47-
1 p.
|
artikel
|
| 9 |
Activation of the coagulation cascade during thrombolysis in unstable angina pectoris
|
|
|
1993
|
70 |
S1 |
p. S92-
1 p.
|
artikel
|
| 10 |
Activation of the hemostatic system in nonvalvular atrial fibrillation and its reversal by restoration of sinus rhythm
|
|
|
1993
|
70 |
S1 |
p. S105-
1 p.
|
artikel
|
| 11 |
Additional experimental evidence on the antithrombotic and antiischemic action of a polydeoxyribonucleotide derived drug (defibrotide)
|
|
|
1993
|
70 |
S1 |
p. S137-
1 p.
|
artikel
|
| 12 |
Additive effect of subcutaneous ddavp and heparin on fibrinolytic system
|
|
|
1993
|
70 |
S1 |
p. S64-
1 p.
|
artikel
|
| 13 |
Adrenergic stimulation of tissue-type plasminogen activator release in a model of vascular perfusion in rats
|
Iacoviello, Licia
|
|
1993
|
70 |
S1 |
p. S77-
1 p.
|
artikel
|
| 14 |
A messanger-like function of oxygen free radicals? A positive feedback signal given by OH° “cripto”-OH° in the platelet activation process
|
Iuliano, L.
|
|
1993
|
70 |
S1 |
p. S9-
1 p.
|
artikel
|
| 15 |
A multivariate analysis of factors predicting the response to plasma exchange in thrombotic microangiopathy (TM) patients
|
|
|
1993
|
70 |
S1 |
p. S96-
1 p.
|
artikel
|
| 16 |
An antithrombin iii (atiii) concentrate reduces activation of coagulation during hemodialysis with high biocompatibility membranes
|
|
|
1993
|
70 |
S1 |
p. S108-
1 p.
|
artikel
|
| 17 |
A new variant of factor X (F X Vicenza)
|
|
|
1993
|
70 |
S1 |
p. S33-
1 p.
|
artikel
|
| 18 |
Anticardiolipin antibodies and deficit of inhibitors in patients affected by deep venous thrombosis or pulmonary embolism
|
|
|
1993
|
70 |
S1 |
p. S127-
1 p.
|
artikel
|
| 19 |
Anticardiolipin antibodies in various thyroid diseases
|
|
|
1993
|
70 |
S1 |
p. S85-
1 p.
|
artikel
|
| 20 |
Anticardiolipin antibodies management during pregnancy: our experience
|
|
|
1993
|
70 |
S1 |
p. S85-
1 p.
|
artikel
|
| 21 |
Anticoagulant activity of a distinct subtype of anticardiolipin antibodies is mediated by β2-glycoprotein I
|
|
|
1993
|
70 |
S1 |
p. S68-
1 p.
|
artikel
|
| 22 |
Anticoagulant activity of anticardiolipin antibodies is blocked by a monoclonal antibody anti-Beta2-glicoprotein I (Beta2-GPI)
|
Ferro, D.
|
|
1993
|
70 |
S1 |
p. S68-
1 p.
|
artikel
|
| 23 |
Antimetastatic activity of different heparins on B16Bl6 melanoma in mice
|
|
|
1993
|
70 |
S1 |
p. S147-
1 p.
|
artikel
|
| 24 |
Antiphospholipid antibodies and physiological antithrombotic mechanisms
|
|
|
1993
|
70 |
S1 |
p. S126-
1 p.
|
artikel
|
| 25 |
Antiphospholipid antibodies and thrombophilia
|
Brancaccio, V.
|
|
1993
|
70 |
S1 |
p. S83-
1 p.
|
artikel
|
| 26 |
Antiphospholipid antibodies and thrombosis our experience
|
|
|
1993
|
70 |
S1 |
p. S83-
1 p.
|
artikel
|
| 27 |
Antiphospholipid antibody (APA) specificity and class distribution in 60 patients with systemic lupus erythematosus (SLE): Biologic and clinical significance
|
|
|
1993
|
70 |
S1 |
p. S70-
1 p.
|
artikel
|
| 28 |
Antiphospholipid antibody syndrome. A case report
|
|
|
1993
|
70 |
S1 |
p. S128-
1 p.
|
artikel
|
| 29 |
Antiphospholipid syndrome associated to pulmonary embolism, vena cava inferior and deep vein thrombosis in a patient with aids
|
|
|
1993
|
70 |
S1 |
p. S86-
1 p.
|
artikel
|
| 30 |
Antithrombotic prophylaxis in hereditary thrombophilia: Lower efficacy in patients with antithrombin III than protein C or S deficiencies
|
|
|
1993
|
70 |
S1 |
p. S26-
1 p.
|
artikel
|
| 31 |
Anti-Xa activity of a new low molecular weight dermatan sulphate
|
|
|
1993
|
70 |
S1 |
p. S73-
1 p.
|
artikel
|
| 32 |
A photometric assay for factor XIII in chronic hepatopathies
|
|
|
1993
|
70 |
S1 |
p. S40-
1 p.
|
artikel
|
| 33 |
Apolipoproteins and lp(a) correlations in patients at risk
|
|
|
1993
|
70 |
S1 |
p. S87-
1 p.
|
artikel
|
| 34 |
A randomized, heparin (H)-controlled, pilot study of dermatan sulfate (DS) in the treatment of disseminated intravascular coagulation in acute leukemia
|
|
|
1993
|
70 |
S1 |
p. S74-
1 p.
|
artikel
|
| 35 |
Ascorbic acid in the treatment of paigg correlated thrombocytopenia: Preliminary results
|
|
|
1993
|
70 |
S1 |
p. S116-
1 p.
|
artikel
|
| 36 |
A simple microtiter plate assay for the quantitation of tissue factor pathway inhibitor in serum and plasma
|
|
|
1993
|
70 |
S1 |
p. S58-
1 p.
|
artikel
|
| 37 |
A simplified compression ultrasound approach for the diagnostic management of clinically suspected deep-vein thrombosis. An interim analysis
|
|
|
1993
|
70 |
S1 |
p. S49-
1 p.
|
artikel
|
| 38 |
Association between altered platelet function and bronchial hyperresponsiveness in nocturnal asthma
|
|
|
1993
|
70 |
S1 |
p. S12-
1 p.
|
artikel
|
| 39 |
Association between thrombocytopenia and functional protein S deficit in lupus anticoagulant
|
|
|
1993
|
70 |
S1 |
p. S126-
1 p.
|
artikel
|
| 40 |
Atherogenic lipoproteins and PAI-1 synthesis by endothelial cells
|
|
|
1993
|
70 |
S1 |
p. S60-
1 p.
|
artikel
|
| 41 |
Author index
|
|
|
1993
|
70 |
S1 |
p. S167-S176
10 p.
|
artikel
|
| 42 |
Automation of kaolin clotting time for the detection of lupus anticoagulant: A comparison between reagents and instrumentations
|
|
|
1993
|
70 |
S1 |
p. S71-
1 p.
|
artikel
|
| 43 |
Behaviour of vitamin e, a and c in patients with documented coronary artery disease
|
Censi, C
|
|
1993
|
70 |
S1 |
p. S143-
1 p.
|
artikel
|
| 44 |
Bezafibrate lowers plasma lipids, fibrinogen and platelet aggregability in hypertriglyceridemic patients
|
|
|
1993
|
70 |
S1 |
p. S141-
1 p.
|
artikel
|
| 45 |
Biochemical and pharmacologic profiling of suleparoide and sulodexide
|
|
|
1993
|
70 |
S1 |
p. S140-
1 p.
|
artikel
|
| 46 |
Blood coagulation system activation in breast cancer: the role of chemotherapy
|
|
|
1993
|
70 |
S1 |
p. S103-
1 p.
|
artikel
|
| 47 |
Ca++ movements during tumor cell induced platelet aggregation
|
Pacchiarini, L.
|
|
1993
|
70 |
S1 |
p. S10-
1 p.
|
artikel
|
| 48 |
Caracterization of molecular lesions causing protein C deficiency (type I and II)
|
|
|
1993
|
70 |
S1 |
p. S20-
1 p.
|
artikel
|
| 49 |
Carrier detection and prenatal diagnosis of hemophilia B by polymerase chain reaction
|
|
|
1993
|
70 |
S1 |
p. S20-
1 p.
|
artikel
|
| 50 |
Cathepsin G (CG)-dependent platelet activation by polymorphonuclear leukocytes (PMN): Role of P-selectin-mediated cell-cell adhesion
|
|
|
1993
|
70 |
S1 |
p. S44-
1 p.
|
artikel
|
| 51 |
Cathepsin G-induced changes of platelet surface glycoproteins
|
|
|
1993
|
70 |
S1 |
p. S111-
1 p.
|
artikel
|
| 52 |
Cathepsin G induces reversible changes in morphology and cytoskeleton arrangement of endothelial cells
|
Kolpakov, Valery
|
|
1993
|
70 |
S1 |
p. S61-
1 p.
|
artikel
|
| 53 |
Changes in primary hemostasis during thrombus formation in a model of arterial thrombosis in rats
|
Chabielska, Ewa
|
|
1993
|
70 |
S1 |
p. S129-
1 p.
|
artikel
|
| 54 |
Changes of prothrombin fragment 1.2 (f1.2), thrombin-antithrombin complex (tat) and fibrinopeptide a (fpa) in patients with acute myocardial infarction (ami) treated with thrombolytic agents
|
|
|
1993
|
70 |
S1 |
p. S102-
1 p.
|
artikel
|
| 55 |
Changes of the hemostatic balance in a model of aging in rats
|
De Curtis, Amalia
|
|
1993
|
70 |
S1 |
p. S143-
1 p.
|
artikel
|
| 56 |
Circulation platelet activation and antiplastic chemotherapy
|
|
|
1993
|
70 |
S1 |
p. S150-
1 p.
|
artikel
|
| 57 |
Clinical efficacy of desmopressin and consistency of responses to separate infusions in patients with prolonged bleeding time due to congenital platelet defect
|
|
|
1993
|
70 |
S1 |
p. S65-
1 p.
|
artikel
|
| 58 |
Clinical observations on the relationship between idiopathic thrombocytopenic purpura, lupus anticoagulant and anticardiolipin antibody syndrome
|
|
|
1993
|
70 |
S1 |
p. S84-
1 p.
|
artikel
|
| 59 |
Combined infusion of streptokinase plus rt-PA in acute myocardial infarction. A comparison with streptokinase alone
|
|
|
1993
|
70 |
S1 |
p. S92-
1 p.
|
artikel
|
| 60 |
Comparison of different methods for the measurement of prothrombin fragment 1+2
|
|
|
1993
|
70 |
S1 |
p. S56-
1 p.
|
artikel
|
| 61 |
Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal-vein thrombosis
|
|
|
1993
|
70 |
S1 |
p. S51-
1 p.
|
artikel
|
| 62 |
Comparison of three commercial assays for the determination of prothrombin fragment l&2 in healthy subjects and in patients on oral anticoagulant treatment
|
|
|
1993
|
70 |
S1 |
p. S23-
1 p.
|
artikel
|
| 63 |
Computerized prescription of oral anticoagulant therapy
|
|
|
1993
|
70 |
S1 |
p. S24-
1 p.
|
artikel
|
| 64 |
Conspicuous hemostasis activation in children and adolescents affected by cystic fibrosis
|
Violante, N.
|
|
1993
|
70 |
S1 |
p. S156-
1 p.
|
artikel
|
| 65 |
Current trends in the development of new antithrombotic drugs
|
|
|
1993
|
70 |
S1 |
p. S163-
1 p.
|
artikel
|
| 66 |
Current venographic aspects of proximal deep-vein thrombosis (DVT): Diagnostic implications
|
|
|
1993
|
70 |
S1 |
p. S50-
1 p.
|
artikel
|
| 67 |
D-dimer plasma levels in patients with ovarian carcinoma: correlation with disease status
|
|
|
1993
|
70 |
S1 |
p. S149-
1 p.
|
artikel
|
| 68 |
Decrease in protein c during treatment with interleukin 2
|
Leone, G.
|
|
1993
|
70 |
S1 |
p. S107-
1 p.
|
artikel
|
| 69 |
Decrease of protein c and protein s plasma levels in patients treated with adjuvant chemotherapy (ct)
|
|
|
1993
|
70 |
S1 |
p. S80-
1 p.
|
artikel
|
| 70 |
Deep-vein thrombosis and the incidence of subsequent malignant disease
|
|
|
1993
|
70 |
S1 |
p. S39-
1 p.
|
artikel
|
| 71 |
Defibrotide in the prevention of peptichemio-induced thrombophlebitis
|
|
|
1993
|
70 |
S1 |
p. S138-
1 p.
|
artikel
|
| 72 |
Defibrotide protects mice from death in a model of thrombin induced thromboembolism: role of fibrinolysis
|
|
|
1993
|
70 |
S1 |
p. S140-
1 p.
|
artikel
|
| 73 |
Degradation of von willebrand factor in patients with leukemias, cirrhosis and pancreatitis
|
|
|
1993
|
70 |
S1 |
p. S101-
1 p.
|
artikel
|
| 74 |
Deletion of exons 26–34 (domain D3-A3) of von Willebrand factor gene in the von Willebrand disease type II
|
|
|
1993
|
70 |
S1 |
p. S19-
1 p.
|
artikel
|
| 75 |
Detection and characterization of polymorphic markers in the factor VII gene
|
|
|
1993
|
70 |
S1 |
p. S19-
1 p.
|
artikel
|
| 76 |
Detection of platelet abnormalities in patients with myelodysplastic syndromes using flow cytometry
|
|
|
1993
|
70 |
S1 |
p. S117-
1 p.
|
artikel
|
| 77 |
Determination of hydrolysis mechanism of amide substrates by human α-thrombin
|
|
|
1993
|
70 |
S1 |
p. S21-
1 p.
|
artikel
|
| 78 |
Determination of hydrolysis mechanisn and measurement of equilibrium binding constant in thrombin-fibrinogen interaction: Effect of pH
|
|
|
1993
|
70 |
S1 |
p. S22-
1 p.
|
artikel
|
| 79 |
Determination of protein S: comparison of methods
|
|
|
1993
|
70 |
S1 |
p. S58-
1 p.
|
artikel
|
| 80 |
Determination of von willebrand factor and factor XIII in schonlein henoch purpura syndrome∗
|
|
|
1993
|
70 |
S1 |
p. S100-
1 p.
|
artikel
|
| 81 |
Diabetic polyneuropathy and endothelial dysfunction
|
|
|
1993
|
70 |
S1 |
p. S147-
1 p.
|
artikel
|
| 82 |
Diagnosis of qualitative platelet disorders
|
|
|
1993
|
70 |
S1 |
p. S1-
1 p.
|
artikel
|
| 83 |
Different clotting and fibrinolytic parameters after bezafibrate treatment in healthy subjects
|
|
|
1993
|
70 |
S1 |
p. S141-
1 p.
|
artikel
|
| 84 |
Different effects of DDAVP infusion on plasma levels of tissue-type plasminogen activator, von willebrand factor and endothelin-1
|
|
|
1993
|
70 |
S1 |
p. S63-
1 p.
|
artikel
|
| 85 |
Differential effect of modified ldl on the expression of procoagulant activity by monocytes and endothelial cells
|
|
|
1993
|
70 |
S1 |
p. S59-
1 p.
|
artikel
|
| 86 |
Different responses to ddavp in patients with acquired hemophilia
|
|
|
1993
|
70 |
S1 |
p. S65-
1 p.
|
artikel
|
| 87 |
Duplex ultrasound diagnosis of deep vein thrombosis (DVT) in symptomatic inpatients
|
|
|
1993
|
70 |
S1 |
p. S48-
1 p.
|
artikel
|
| 88 |
Early molecular events in cd69-mediated platelet activation
|
Pulcinelli, F.M.
|
|
1993
|
70 |
S1 |
p. S9-
1 p.
|
artikel
|
| 89 |
Ecocardiographic lesions in patients suffering from lupus nephritis
|
|
|
1993
|
70 |
S1 |
p. S127-
1 p.
|
artikel
|
| 90 |
Effect of all-transretinoic acid on procoagulant activity of promyelocytic blast cells in culture
|
Teofili, L.
|
|
1993
|
70 |
S1 |
p. S55-
1 p.
|
artikel
|
| 91 |
Effect of binding of C-terminal domain of hirudin on the amidase activity of human α-thrombin
|
|
|
1993
|
70 |
S1 |
p. S21-
1 p.
|
artikel
|
| 92 |
Effect of cyclooxygenase blockade on different platelet functions activated by tumor cells
|
|
|
1993
|
70 |
S1 |
p. S11-
1 p.
|
artikel
|
| 93 |
Effect of dialysis membranes having different biocompatibility on protein C and protein S
|
|
|
1993
|
70 |
S1 |
p. S123-
1 p.
|
artikel
|
| 94 |
Effect of low molecular weight heparins (LMWHs) on fibrin polymerization and on clot sensitivity to t-PA-induced lysis
|
|
|
1993
|
70 |
S1 |
p. S16-
1 p.
|
artikel
|
| 95 |
Effect of standard heparin and low M.W. heparin(CY 216) on plasma levels of tissue factor pathway inhibitor
|
|
|
1993
|
70 |
S1 |
p. S15-
1 p.
|
artikel
|
| 96 |
Effect of storage of plasma and euglobulin precipitates on ELT
|
|
|
1993
|
70 |
S1 |
p. S57-
1 p.
|
artikel
|
| 97 |
Effect of unfractionated heparin (UH) and a LMWH (CY 216) on fibrinolysis in vivo
|
|
|
1993
|
70 |
S1 |
p. S18-
1 p.
|
artikel
|
| 98 |
Effects of a very low calorie diet (vlcd) on the levels of hematological risk factors for cardiovascular disease in highly obese men
|
|
|
1993
|
70 |
S1 |
p. S90-
1 p.
|
artikel
|
| 99 |
Effects of cathepsin g on the mitogenic capacity of subendothelial matrix
|
|
|
1993
|
70 |
S1 |
p. S145-
1 p.
|
artikel
|
| 100 |
Effects of desmopressin on haemostasis in patients with liver cyrrhosis
|
|
|
1993
|
70 |
S1 |
p. S66-
1 p.
|
artikel
|
| 101 |
Effects of fibrin/ogen degradation products on erythrocyte aggregation
|
|
|
1993
|
70 |
S1 |
p. S152-
1 p.
|
artikel
|
| 102 |
Effects of heparin and dermatan sulfate on injured vessel wall hyperplasia
|
|
|
1993
|
70 |
S1 |
p. S72-
1 p.
|
artikel
|
| 103 |
Effects of heparin (H) and low-molecular-weight dermatan-sulfate (D) on clot-bound (CT) VS fluid-phase thrombin (FT)
|
|
|
1993
|
70 |
S1 |
p. S72-
1 p.
|
artikel
|
| 104 |
Effects of low molecular weight heparin(parnaparin) on exercise tolerance in chronic, stable angina
|
|
|
1993
|
70 |
S1 |
p. S135-
1 p.
|
artikel
|
| 105 |
Effects of n-3 polyunsaturated fatty acids (PUFA) on parameters of granulocyte function in humans
|
|
|
1993
|
70 |
S1 |
p. S47-
1 p.
|
artikel
|
| 106 |
Effects of trasylolR on hemostasis in patients undergoing cardiopulmonary bypass
|
Martínez-Brotóns, F.
|
|
1993
|
70 |
S1 |
p. S94-
1 p.
|
artikel
|
| 107 |
Effects of unopposed estrogen therapy on hemostatic system in menopausal women
|
|
|
1993
|
70 |
S1 |
p. S38-
1 p.
|
artikel
|
| 108 |
Efficacy of octreotide and desmopressin in reducing blood loss in patients with angiodysplasia
|
|
|
1993
|
70 |
S1 |
p. S157-
1 p.
|
artikel
|
| 109 |
Endothelial cell taxis towards blood cells
|
|
|
1993
|
70 |
S1 |
p. S62-
1 p.
|
artikel
|
| 110 |
Enhancement of thrombosis induced in spontaneous hypertensive rats
|
|
|
1993
|
70 |
S1 |
p. S128-
1 p.
|
artikel
|
| 111 |
Enzyme-immunosorbent assay of human c4b-binding protein by using monoclonal antibodies
|
|
|
1993
|
70 |
S1 |
p. S154-
1 p.
|
artikel
|
| 112 |
Epidemiological feasibility of a trial of aspirin in the primary prevention of vascular events in the general practice
|
|
|
1993
|
70 |
S1 |
p. S90-
1 p.
|
artikel
|
| 113 |
Essential thrombocythemia and thrombotic events : role of PAI
|
|
|
1993
|
70 |
S1 |
p. S53-
1 p.
|
artikel
|
| 114 |
Evaluation of clotting and fibrinolytic activation in ischemic heart disease
|
|
|
1993
|
70 |
S1 |
p. S93-
1 p.
|
artikel
|
| 115 |
Evaluation of coagulation activity during psoriasis
|
|
|
1993
|
70 |
S1 |
p. S105-
1 p.
|
artikel
|
| 116 |
Evaluation of coagulation test in neoplastic patients
|
|
|
1993
|
70 |
S1 |
p. S150-
1 p.
|
artikel
|
| 117 |
Evaluation of fragment 1+2 in patients on oral anticoagulant therapy
|
|
|
1993
|
70 |
S1 |
p. S22-
1 p.
|
artikel
|
| 118 |
Evaluation of immunological and functional fibrinogen (fgn) assays
|
|
|
1993
|
70 |
S1 |
p. S151-
1 p.
|
artikel
|
| 119 |
Evaluation of the coagulation monitor 512 (cm 512) for its ability to perform prothrombin time (pt) test in patients on oral anticoagulants
|
|
|
1993
|
70 |
S1 |
p. S136-
1 p.
|
artikel
|
| 120 |
Evaluation of the pharmacological interaction between defibrotide and heparin inpatients with total hip replacement
|
|
|
1993
|
70 |
S1 |
p. S139-
1 p.
|
artikel
|
| 121 |
Evaluation of various specific autoantibodies in chronic idiopathic thrombocytopenia
|
Ferretti, A.
|
|
1993
|
70 |
S1 |
p. S115-
1 p.
|
artikel
|
| 122 |
Extravascular proteolysis and fibrin deposits in breast cancer
|
|
|
1993
|
70 |
S1 |
p. S79-
1 p.
|
artikel
|
| 123 |
Familial thrombophilia
|
|
|
1993
|
70 |
S1 |
p. S6-
1 p.
|
artikel
|
| 124 |
Fibrinogen degradation products (FgDG) generation is the major determinant of platelet inhibition induced by plasminogen activators (PA)
|
|
|
1993
|
70 |
S1 |
p. S112-
1 p.
|
artikel
|
| 125 |
Fibrinolysis and thrombosis
|
|
|
1993
|
70 |
S1 |
p. S5-
1 p.
|
artikel
|
| 126 |
Fibrinolytic variables in prediction of atherothrombotic sequelae in patients with preexisting vascular ischaemic disease : the plat study
|
|
|
1993
|
70 |
S1 |
p. S87-
1 p.
|
artikel
|
| 127 |
F1+2 levels in patients suffering from juvenile venous thrombosis (jvt) with or without ascertained clotting changes
|
|
|
1993
|
70 |
S1 |
p. S102-
1 p.
|
artikel
|
| 128 |
Functional characterization of monoclonal antibodies against tissue type human plasminogen activator (tPA)
|
|
|
1993
|
70 |
S1 |
p. S146-
1 p.
|
artikel
|
| 129 |
Functional study of an abnormal prothrombin: Prothrombin Segovia
|
|
|
1993
|
70 |
S1 |
p. S31-
1 p.
|
artikel
|
| 130 |
Function of gplbα in platelet Na+/H+ exchanger activation induced by human α-thrombin
|
|
|
1993
|
70 |
S1 |
p. S12-
1 p.
|
artikel
|
| 131 |
Fviii:C-vwf:Ag,fibrinogen,pai-1 and leucocytes are associated with ischemic events in vascular disease patients: the plat study
|
|
|
1993
|
70 |
S1 |
p. S86-
1 p.
|
artikel
|
| 132 |
Glanzmann's thrombasthenia: Flow cytometric analysis
|
|
|
1993
|
70 |
S1 |
p. S29-
1 p.
|
artikel
|
| 133 |
Glycosaminoglycans: Pharmacological properties and methods of assessing clinical efficacy
|
|
|
1993
|
70 |
S1 |
p. S162-
1 p.
|
artikel
|
| 134 |
Haemorheology and diabetic microangiopathy
|
|
|
1993
|
70 |
S1 |
p. S142-
1 p.
|
artikel
|
| 135 |
Haemostasis and estrogen-progesterone therapy in turner's syndrome
|
|
|
1993
|
70 |
S1 |
p. S129-
1 p.
|
artikel
|
| 136 |
Haemostatic changes after bone marrow transplantation
|
Testa, S.
|
|
1993
|
70 |
S1 |
p. S148-
1 p.
|
artikel
|
| 137 |
Haemostatic evaluation in a newborn from mother affected by congenital deficiency of factor X: Hypothesis of transplacental passage of factor X
|
|
|
1993
|
70 |
S1 |
p. S33-
1 p.
|
artikel
|
| 138 |
Heightened proteolysis of von willebrand factor in plasma concentrates
|
|
|
1993
|
70 |
S1 |
p. S100-
1 p.
|
artikel
|
| 139 |
Hemorheological effects of a very low calorie diet (VLCD) in obese subjects
|
|
|
1993
|
70 |
S1 |
p. S91-
1 p.
|
artikel
|
| 140 |
Hemostasis in liver transplantation
|
Castillo, R.
|
|
1993
|
70 |
S1 |
p. S1-
1 p.
|
artikel
|
| 141 |
Hemostasis in orthotopic liver transplantation (OLT)
|
|
|
1993
|
70 |
S1 |
p. S43-
1 p.
|
artikel
|
| 142 |
Hemostatic system in women with pharmacological menopause
|
|
|
1993
|
70 |
S1 |
p. S38-
1 p.
|
artikel
|
| 143 |
Heparin infusion facilitates platelets activability in patients with acute myocardial infarction who have undergone thrombolytic therapy
|
|
|
1993
|
70 |
S1 |
p. S14-
1 p.
|
artikel
|
| 144 |
Heparin therapy in intracranial sinus venous thrombosis
|
|
|
1993
|
70 |
S1 |
p. S132-
1 p.
|
artikel
|
| 145 |
Hepatic veins thrombosis treated with rTPA
|
Neviani, A.L.
|
|
1993
|
70 |
S1 |
p. S133-
1 p.
|
artikel
|
| 146 |
Hereditary macrothrombocytopenia with leukocyte inclusions: Report of 12 cases
|
|
|
1993
|
70 |
S1 |
p. S54-
1 p.
|
artikel
|
| 147 |
Heterogeneity of protein S defects
|
|
|
1993
|
70 |
S1 |
p. S124-
1 p.
|
artikel
|
| 148 |
H202 evoked calcium transient in platelets
|
Pratico, D.
|
|
1993
|
70 |
S1 |
p. S10-
1 p.
|
artikel
|
| 149 |
High dose defibrotide+warfarin in a patient with post-heparin DVT
|
|
|
1993
|
70 |
S1 |
p. S138-
1 p.
|
artikel
|
| 150 |
High dose intravenous immunoglobulins and DDAVP for the management of a patient with acquired von willebrand disease (AvWD) undergoing hemorrhoidectomy
|
|
|
1993
|
70 |
S1 |
p. S66-
1 p.
|
artikel
|
| 151 |
High fibrinogen plasma level as a marker of increased thrombin formation
|
|
|
1993
|
70 |
S1 |
p. S104-
1 p.
|
artikel
|
| 152 |
High prevalence of low protein c and s levels in patients suffering from migraine
|
|
|
1993
|
70 |
S1 |
p. S106-
1 p.
|
artikel
|
| 153 |
(3H)-norepinephrine spillover in patients with primary raynaud phenomenon
|
|
|
1993
|
70 |
S1 |
p. S89-
1 p.
|
artikel
|
| 154 |
Homocysteine (HCy) levels in young patients with venous thromboembolism
|
|
|
1993
|
70 |
S1 |
p. S40-
1 p.
|
artikel
|
| 155 |
Homozygous deficiency of protein c with neonatal deep vein thrombosis and new symptoms at young age
|
De Stefano, V.
|
|
1993
|
70 |
S1 |
p. S107-
1 p.
|
artikel
|
| 156 |
3H-picotamide binding to human platelets
|
|
|
1993
|
70 |
S1 |
p. S113-
1 p.
|
artikel
|
| 157 |
HPLC method for the determination of total homocysteine and definition of reference values
|
|
|
1993
|
70 |
S1 |
p. S154-
1 p.
|
artikel
|
| 158 |
Human T cell clones ability of inducing monocyte procoagulant activity
|
Giusti, B.
|
|
1993
|
70 |
S1 |
p. S45-
1 p.
|
artikel
|
| 159 |
Hypercoagulability under L-asparaginase therapy in acute lymphoblastic leukemia (ALL) : The role of antithrombin III supplementation in vivo
|
|
|
1993
|
70 |
S1 |
p. S55-
1 p.
|
artikel
|
| 160 |
Il-1β and il-6 release by peripheral blood monocytes in head and neck cancer
|
Martini, F.
|
|
1993
|
70 |
S1 |
p. S81-
1 p.
|
artikel
|
| 161 |
Immunologic studies in HIV positive and HIV negative hemophiliacs receiving recombinant FVIII (KOGENATE) - A 3 year update
|
|
|
1993
|
70 |
S1 |
p. S165-
1 p.
|
artikel
|
| 162 |
Importance of obstetrical and gynecological factors as trigger causes of venous thromboembolic episodes (VTE) in young females
|
|
|
1993
|
70 |
S1 |
p. S39-
1 p.
|
artikel
|
| 163 |
Increased platelet expression of fibronectin (VLA-4,VLA-5) and vitronectin (VNRa) receptors and of CD69 in patients with essential thrombocythemia
|
|
|
1993
|
70 |
S1 |
p. S53-
1 p.
|
artikel
|
| 164 |
Increase of PAI-1 plasma levels following adjuvant chemotherapy (ct)
|
|
|
1993
|
70 |
S1 |
p. S149-
1 p.
|
artikel
|
| 165 |
Influence of the administration of DDAVP versus aprotinin in the prevention of bleeding after cardiac surgery
|
|
|
1993
|
70 |
S1 |
p. S64-
1 p.
|
artikel
|
| 166 |
Inherited thrombophilic syndromes: Experience of a department of hematology
|
Castaman, G.
|
|
1993
|
70 |
S1 |
p. S36-
1 p.
|
artikel
|
| 167 |
Inhibition of fluid phase and clot-bound thrombin: Effects of heparin, hirudin and PEG-rm-hirudin
|
|
|
1993
|
70 |
S1 |
p. S17-
1 p.
|
artikel
|
| 168 |
Inhibition of polyamines on platelet responses
|
|
|
1993
|
70 |
S1 |
p. S27-
1 p.
|
artikel
|
| 169 |
Inhibitor against factor VIII in affected members of a mild hemophilia family
|
|
|
1993
|
70 |
S1 |
p. S34-
1 p.
|
artikel
|
| 170 |
Interaction between factor XII and human endothelial cells in culture
|
|
|
1993
|
70 |
S1 |
p. S62-
1 p.
|
artikel
|
| 171 |
Interaction between platelet and endothelial cell matrix (ecm) in patients with breas cancer: effect of chemotherapy
|
|
|
1993
|
70 |
S1 |
p. S79-
1 p.
|
artikel
|
| 172 |
Interaction of high-density lipoproteins with platelet function
|
|
|
1993
|
70 |
S1 |
p. S114-
1 p.
|
artikel
|
| 173 |
Interleukin-6 (il-6) and acute phase proteins in head and neck cancer (hnsc)
|
Attanasio, M.
|
|
1993
|
70 |
S1 |
p. S81-
1 p.
|
artikel
|
| 174 |
Intravascular clotting activation and secondary hyperfibrinolysis in liver cirrhosis (LC) patients
|
Basili, S
|
|
1993
|
70 |
S1 |
p. S41-
1 p.
|
artikel
|
| 175 |
Intravenous immunoglobulins were effective in the suppression of inhibitors in a patient with acquired hemophilia
|
Schiavoni, M.
|
|
1993
|
70 |
S1 |
p. S122-
1 p.
|
artikel
|
| 176 |
“In vitro” and “ex vivo” inhibition of monocyte procoagulant activity by the stable prostacyclin analog, iloprost
|
|
|
1993
|
70 |
S1 |
p. S46-
1 p.
|
artikel
|
| 177 |
In vitro and in vivo study of an Italian highly purified human factor IX concentrate
|
|
|
1993
|
70 |
S1 |
p. S32-
1 p.
|
artikel
|
| 178 |
In vitro antiaggregating effect of a pyridazinone-derivative compound
|
|
|
1993
|
70 |
S1 |
p. S113-
1 p.
|
artikel
|
| 179 |
In vitro evaluation of the magnetic field effects on some haemostasis parameters, during a RM examination
|
|
|
1993
|
70 |
S1 |
p. S158-
1 p.
|
artikel
|
| 180 |
In vitro inhibiton by s-adenosyl-l-methionine of granulocyte superoxide anion generation
|
|
|
1993
|
70 |
S1 |
p. S146-
1 p.
|
artikel
|
| 181 |
In vivo inhibition of prothrombin activation follows the reduction of factor ii in the early phase of oral anticoagulant treatment
|
|
|
1993
|
70 |
S1 |
p. S23-
1 p.
|
artikel
|
| 182 |
Kinetics of ADP-induced platelet aggregation
|
|
|
1993
|
70 |
S1 |
p. S59-
1 p.
|
artikel
|
| 183 |
Kinetics of plasma thrombin neutralizing activity in patients with deep vein thrombosis treated with subcutaneous heparin B.I.D.
|
|
|
1993
|
70 |
S1 |
p. S51-
1 p.
|
artikel
|
| 184 |
Lipids and platelet function modifications during exercise stress test
|
|
|
1993
|
70 |
S1 |
p. S112-
1 p.
|
artikel
|
| 185 |
Low circulating levels of beta 2 gltcoprotein I (Beta 2 GPI) in patients with different degrees of liver cirrhosis
|
Quintarelli, C.
|
|
1993
|
70 |
S1 |
p. S43-
1 p.
|
artikel
|
| 186 |
Low fibrinolytic potential is a risk factor for recurrent myocardial infarction
|
|
|
1993
|
70 |
S1 |
p. S94-
1 p.
|
artikel
|
| 187 |
Low molecular weight heparin is more active than unfractionated heparin in platelet rich environments
|
|
|
1993
|
70 |
S1 |
p. S135-
1 p.
|
artikel
|
| 188 |
Low rate of thrombotic and hemorrhagic complications in patients with mechanical prosthetic heart valves attending an anticoagulation clinic
|
|
|
1993
|
70 |
S1 |
p. S25-
1 p.
|
artikel
|
| 189 |
Lupus anticoagulant,antiphospholipid and anticardiolipid antibodies and HIV infection in haemophilia
|
|
|
1993
|
70 |
S1 |
p. S71-
1 p.
|
artikel
|
| 190 |
Lupus anticoagulant (LA) and fibrinolytic system in SLE and non-SLE women with repeated abortions
|
Ferro, D.
|
|
1993
|
70 |
S1 |
p. S69-
1 p.
|
artikel
|
| 191 |
Management of pregnancy in an woman with congenital true deficiency of prothrombin
|
|
|
1993
|
70 |
S1 |
p. S32-
1 p.
|
artikel
|
| 192 |
Markers of the prethrombotic states
|
|
|
1993
|
70 |
S1 |
p. S6-
1 p.
|
artikel
|
| 193 |
Measurement of polymorfonuclear leukocytes-derived hydrogen peroxide in whole blood
|
Pratico, D.
|
|
1993
|
70 |
S1 |
p. S48-
1 p.
|
artikel
|
| 194 |
Mechanisms for the antithrombotic effects of glycosaminoglycans
|
|
|
1993
|
70 |
S1 |
p. S161-
1 p.
|
artikel
|
| 195 |
Mechanisms of action of antiphospholipid antibodies and their clinical relevance
|
|
|
1993
|
70 |
S1 |
p. S3-
1 p.
|
artikel
|
| 196 |
Microangiopathic haemolitic anaemia (MAHA), A rare complication of gastrointestinal tumors with bone marrow metastases: our experience
|
|
|
1993
|
70 |
S1 |
p. S82-
1 p.
|
artikel
|
| 197 |
Modifications of lymphocyte subsets and of interleukin 2 serum levels in autoimmune thrombocytopenic purpura
|
|
|
1993
|
70 |
S1 |
p. S54-
1 p.
|
artikel
|
| 198 |
Modulation of cell surface proteolytic map by recycling of the urokinase receptor
|
|
|
1993
|
70 |
S1 |
p. S76-
1 p.
|
artikel
|
| 199 |
Monitoring platelet function in thrombotic thrombocytopenic purpurr (TTP) by flow cytometry
|
|
|
1993
|
70 |
S1 |
p. S97-
1 p.
|
artikel
|
| 200 |
Monocytes, inflammation and hemostasis
|
Altieri, Dario C.
|
|
1993
|
70 |
S1 |
p. S4-
1 p.
|
artikel
|
| 201 |
Monocytic regulation of vascular cell fibrinolysis. Role of cytokines
|
|
|
1993
|
70 |
S1 |
p. S76-
1 p.
|
artikel
|
| 202 |
Morphological-morphometrical studies of platelets and endothelial cells after “in vivo” and “in vitro” activation
|
|
|
1993
|
70 |
S1 |
p. S159-
1 p.
|
artikel
|
| 203 |
Multidisciplinary approach to thrombotic thrombocytopenic purpura-hemolytic uremic syndrome:Ad HOC study group
|
|
|
1993
|
70 |
S1 |
p. S98-
1 p.
|
artikel
|
| 204 |
Multimeric analysis of von Willebrand factor (vWF) in patients with lupus anticoagulant (LA)
|
|
|
1993
|
70 |
S1 |
p. S70-
1 p.
|
artikel
|
| 205 |
Multiple dental extractions in patients with hemophilia: presentation of two cases
|
|
|
1993
|
70 |
S1 |
p. S121-
1 p.
|
artikel
|
| 206 |
Multiple glycoprotein abnormalities in the platelets of a young patient with a severe bleeding tendency
|
|
|
1993
|
70 |
S1 |
p. S31-
1 p.
|
artikel
|
| 207 |
Nabumetone, a new non-steroidal anti-inflammatory drug (nsaid) does not inhibit renal production of prostaglandins.
|
|
|
1993
|
70 |
S1 |
p. S156-
1 p.
|
artikel
|
| 208 |
Negativization of anti-phospholipid antibodies and lupus anticoagulant activity in acute myeloid leukemias (AML) and in non hodgkin's lymphomas (nhl) parallels response to therapy
|
Stipa, E.
|
|
1993
|
70 |
S1 |
p. S84-
1 p.
|
artikel
|
| 209 |
Nitroglycerin infusion: Hemodynamic and anti-platelets effects in patients with cardiomyopathy
|
|
|
1993
|
70 |
S1 |
p. S30-
1 p.
|
artikel
|
| 210 |
No cell is an island: a personal view on the pathogenesis of arterial thrombosis
|
|
|
1993
|
70 |
S1 |
p. S2-
1 p.
|
artikel
|
| 211 |
N-3 polyunsaturated fatty acids and vascular disease
|
|
|
1993
|
70 |
S1 |
p. S5-
1 p.
|
artikel
|
| 212 |
n-3 polyunsaturated fatty acids reduce proteinuria in patients with chronic glomerular disease
|
|
|
1993
|
70 |
S1 |
p. S155-
1 p.
|
artikel
|
| 213 |
Outcome of hip surgery patients with lower limb-negative venography at discharge
|
|
|
1993
|
70 |
S1 |
p. S50-
1 p.
|
artikel
|
| 214 |
Pathogenetic role of ascitic fluid in the hyperfibrinolytic syndrome of patients with liver cirrhosis
|
|
|
1993
|
70 |
S1 |
p. S42-
1 p.
|
artikel
|
| 215 |
Pathophysiology and clinical pharmacology of the thromboxane/prostacyclin balance: a critical appraisal
|
|
|
1993
|
70 |
S1 |
p. S4-
1 p.
|
artikel
|
| 216 |
Pharmacodynamic properties of a new low molecular weight heparin, parnaparin
|
|
|
1993
|
70 |
S1 |
p. S162-
1 p.
|
artikel
|
| 217 |
Pharmacokinetics of dermatan sulfate MF701 during haemodialysis
|
|
|
1993
|
70 |
S1 |
p. S73-
1 p.
|
artikel
|
| 218 |
Pharmacokinetics of intramuscular dermatan sulfate (MF701) in patients with hip fracture
|
|
|
1993
|
70 |
S1 |
p. S74-
1 p.
|
artikel
|
| 219 |
Plasma and platelet protein S antigen
|
|
|
1993
|
70 |
S1 |
p. S122-
1 p.
|
artikel
|
| 220 |
Plasma from patients with type IIB von willebrand disease induces cytosolic ca2+ increase in human platelets
|
|
|
1993
|
70 |
S1 |
p. S120-
1 p.
|
artikel
|
| 221 |
Plasma levels of t-pa, u-pa, pai-1 and pai-2 in breast cancer patients
|
|
|
1993
|
70 |
S1 |
p. S80-
1 p.
|
artikel
|
| 222 |
Plasma thrombin neutralization assay (PTNA): A sensitive method to detect heparin in plasma
|
|
|
1993
|
70 |
S1 |
p. S56-
1 p.
|
artikel
|
| 223 |
Plasminogen activation on cell surfaces
|
|
|
1993
|
70 |
S1 |
p. S3-
1 p.
|
artikel
|
| 224 |
Plasminogen and tissue-type plasminogen activator (tPA) share a common binding site on monocytoid cells
|
|
|
1993
|
70 |
S1 |
p. S75-
1 p.
|
artikel
|
| 225 |
Plasminogen bound to its cellular receptor is rapidly activated by tPA
|
|
|
1993
|
70 |
S1 |
p. S75-
1 p.
|
artikel
|
| 226 |
Platelet function detected by flowcytometry in a pregnant thrombocytemic with extensive mesenteric thrombosis
|
|
|
1993
|
70 |
S1 |
p. S117-
1 p.
|
artikel
|
| 227 |
Platelet-neutrophil interaction and generation of superoxide anion: Effect of purine nucleotides
|
|
|
1993
|
70 |
S1 |
p. S111-
1 p.
|
artikel
|
| 228 |
Platelet-PMN leucocyte interaction
|
|
|
1993
|
70 |
S1 |
p. S163-
1 p.
|
artikel
|
| 229 |
Platelets activation and protein C and S in neoplastic patients
|
|
|
1993
|
70 |
S1 |
p. S151-
1 p.
|
artikel
|
| 230 |
Platelet txa2 receptor desensitization and moss and cross talk with adenylate-cyclase: pharmacologic implications
|
|
|
1993
|
70 |
S1 |
p. S13-
1 p.
|
artikel
|
| 231 |
Platelet TxA2 receptors are reduced in IIa hyperlipo-proteinemia
|
|
|
1993
|
70 |
S1 |
p. S29-
1 p.
|
artikel
|
| 232 |
Polymorphism of the Bβ-fibrinogen gene and plasma fibrinogen levels in ischemic stroke
|
|
|
1993
|
70 |
S1 |
p. S18-
1 p.
|
artikel
|
| 233 |
Polymorphonuclear leukocytes increase growth factors release from cultured endothelial cells
|
|
|
1993
|
70 |
S1 |
p. S60-
1 p.
|
artikel
|
| 234 |
Possible role of transforming growth factor beta (TGF-β) on the in vitro proliferation of smooth muscle cells obtained from the thoracic aorta of spontaneously hypertensive rats
|
|
|
1993
|
70 |
S1 |
p. S145-
1 p.
|
artikel
|
| 235 |
Preliminary characterization of a new congenital hypodysfibrinogenemia (vicenza II) and of dysfibrinogenemia genova IV
|
Castaman, G.
|
|
1993
|
70 |
S1 |
p. S119-
1 p.
|
artikel
|
| 236 |
Preliminary characterization of two new congenital dysfibrinogenemias with reduced fibrinopeptide a release (fibrinogen vicenza III and bolzano)
|
|
|
1993
|
70 |
S1 |
p. S120-
1 p.
|
artikel
|
| 237 |
Prevention of deep venous thrombosis (DVT) with low molecular weight (lmw) heparin (fraxiparine) in general and orthopedic surgery
|
|
|
1993
|
70 |
S1 |
p. S134-
1 p.
|
artikel
|
| 238 |
Prevention of restenosis after PTCA: Double blind randomized multicenter study
|
|
|
1993
|
70 |
S1 |
p. S160-
1 p.
|
artikel
|
| 239 |
Primary thrombocythemia in pregnancy
|
|
|
1993
|
70 |
S1 |
p. S116-
1 p.
|
artikel
|
| 240 |
Procoagulant activity and production of interleukin 1β and tumor necrosis factor by monocytes of patients with antiphospholipid antibodies
|
|
|
1993
|
70 |
S1 |
p. S125-
1 p.
|
artikel
|
| 241 |
Production and characterization of factor VIII produced by recombinant DNA technology
|
|
|
1993
|
70 |
S1 |
p. S164-
1 p.
|
artikel
|
| 242 |
Prolonged plasma half-life of the anthia activity of enoxaparin assessed with a sensitive test (PTNA)
|
|
|
1993
|
70 |
S1 |
p. S14-
1 p.
|
artikel
|
| 243 |
Protein C (PC) and antithrombin III (AtIII) replrcement therapy prevents peripartum thrombosis
|
|
|
1993
|
70 |
S1 |
p. S124-
1 p.
|
artikel
|
| 244 |
Prothrombin time (pt)-derived fibrinogen assay: three different commercial systems compared with the clauss method
|
|
|
1993
|
70 |
S1 |
p. S153-
1 p.
|
artikel
|
| 245 |
P-selectin upregulates the synthesis of tissue factor on monocytes
|
|
|
1993
|
70 |
S1 |
p. S46-
1 p.
|
artikel
|
| 246 |
Radiologic contrast media and eicosanoid production from cells involved in thrombosis and hemostasis
|
|
|
1993
|
70 |
S1 |
p. S63-
1 p.
|
artikel
|
| 247 |
Recurrent deep venous thromboses as early sign of progressive systemic sclerosis: A case report
|
|
|
1993
|
70 |
S1 |
p. S131-
1 p.
|
artikel
|
| 248 |
Relationhsip between plasma and platelet fibrinogen concentrations and the bleeding time: Study in an afibrinogenemic patient
|
|
|
1993
|
70 |
S1 |
p. S28-
1 p.
|
artikel
|
| 249 |
Relationships between structure and biological activity of sulfated glycosaminoglycans
|
|
|
1993
|
70 |
S1 |
p. S160-
1 p.
|
artikel
|
| 250 |
Relative effects of heparin and sulodexide on prevention of thrombus formation and growth
|
|
|
1993
|
70 |
S1 |
p. S161-
1 p.
|
artikel
|
| 251 |
Release of cathepsin g from polymorphonuclear leukocytes (pmn) in patients with prosthetic heart valves
|
|
|
1993
|
70 |
S1 |
p. S144-
1 p.
|
artikel
|
| 252 |
Replacement therapy with purified concentrate of protein c in homozygous or heterozygous patients
|
De Stefano, V.
|
|
1993
|
70 |
S1 |
p. S109-
1 p.
|
artikel
|
| 253 |
Report on one case of thrombophilia with familial elevation of histidine-rich glycoprotein
|
|
|
1993
|
70 |
S1 |
p. S131-
1 p.
|
artikel
|
| 254 |
Response to DDAVP in children with langherans cell histiocytosis (LCH) and with diabetes insipidus (DI)
|
|
|
1993
|
70 |
S1 |
p. S157-
1 p.
|
artikel
|
| 255 |
Results with a recombinant thromboplastin reagent
|
|
|
1993
|
70 |
S1 |
p. S153-
1 p.
|
artikel
|
| 256 |
Risk of venous thromboembolism and stroke associated with oral contraceptives containing lower oestrogen dosage
|
|
|
1993
|
70 |
S1 |
p. S37-
1 p.
|
artikel
|
| 257 |
Role of antiplatelet therapy in unstable angina. Controlled clinical trials
|
|
|
1993
|
70 |
S1 |
p. S159-
1 p.
|
artikel
|
| 258 |
Role of endothelin and thrombin generation in the acute phase and the evolution of anterior acute myocardial infarction
|
|
|
1993
|
70 |
S1 |
p. S89-
1 p.
|
artikel
|
| 259 |
Role of p-selectin and cathepsin g in arachidonic acid (aa) transcellular metabolism during platelet-pmn interaction
|
|
|
1993
|
70 |
S1 |
p. S11-
1 p.
|
artikel
|
| 260 |
Role of T and B lymphocytes in inducing monocyte procoagulant activity
|
Lammel, R.M.
|
|
1993
|
70 |
S1 |
p. S45-
1 p.
|
artikel
|
| 261 |
Role of vwf on the proaggregating cysteine proteinase (PACP) activity of thrombotic thrombocytopenic purpura (TTP) with vWF
|
|
|
1993
|
70 |
S1 |
p. S95-
1 p.
|
artikel
|
| 262 |
Safety and efficacy of rFVIII
|
|
|
1993
|
70 |
S1 |
p. S165-
1 p.
|
artikel
|
| 263 |
Seasonal variation of oral anticoagulant effect
|
|
|
1993
|
70 |
S1 |
p. S25-
1 p.
|
artikel
|
| 264 |
Selenium stimulates GSH-Px activity and PGI2 release in human endothelial cells in culture
|
|
|
1993
|
70 |
S1 |
p. S61-
1 p.
|
artikel
|
| 265 |
Severe thromboembolic disease associated with an acquired inhibitor of protein S
|
|
|
1993
|
70 |
S1 |
p. S106-
1 p.
|
artikel
|
| 266 |
Shear-induced platelet aggregation: Potentiation by DDAVP and inhibition by ticlopidine
|
|
|
1993
|
70 |
S1 |
p. S28-
1 p.
|
artikel
|
| 267 |
Sistemic fibrinolytic effect of intraarterial low-dose thrombolysis with urokinase
|
|
|
1993
|
70 |
S1 |
p. S155-
1 p.
|
artikel
|
| 268 |
Slight activation of coagulation after physical exercise
|
|
|
1993
|
70 |
S1 |
p. S88-
1 p.
|
artikel
|
| 269 |
Soybean phospholipids aptt as a confirmatory test for the detection of lupus anticoagulant
|
|
|
1993
|
70 |
S1 |
p. S125-
1 p.
|
artikel
|
| 270 |
Staining for fibrin in the detection of complicated carotid artery plaques
|
|
|
1993
|
70 |
S1 |
p. S142-
1 p.
|
artikel
|
| 271 |
Standardization of fibrinogen assay: the influence of the calibrator
|
|
|
1993
|
70 |
S1 |
p. S152-
1 p.
|
artikel
|
| 272 |
Studies of vWF-botrocetin complex in patients with different subtypes of type ii von willebrand disease
|
|
|
1993
|
70 |
S1 |
p. S99-
1 p.
|
artikel
|
| 273 |
Study of physiologic inhibitors of blood coagulation in polycythemia vera and essential thrombocythaemia
|
|
|
1993
|
70 |
S1 |
p. S52-
1 p.
|
artikel
|
| 274 |
Subcutaneous desmopressin in management of patients with congenital bleeding disorders undergoing dental extractions
|
|
|
1993
|
70 |
S1 |
p. S67-
1 p.
|
artikel
|
| 275 |
Subject index
|
|
|
1993
|
70 |
S1 |
p. S177-S182
6 p.
|
artikel
|
| 276 |
Subtypes of congenital antithrombin III (at-III) deficiency in 596 unrelated young patients with venous thrombosis
|
|
|
1993
|
70 |
S1 |
p. S123-
1 p.
|
artikel
|
| 277 |
Successful management of a patient with an acquired high-titer factor VIII (FVIII) antibody undergoing surgery by extracorporeal immmunoadsorption (EI) and porcine FVIII replacement therapy
|
|
|
1993
|
70 |
S1 |
p. S35-
1 p.
|
artikel
|
| 278 |
Sustained antithrombotic activity of hirudin after its plasma clearance: Comparison with heparin
|
|
|
1993
|
70 |
S1 |
p. S16-
1 p.
|
artikel
|
| 279 |
Symptomatic deep-vein thrombosis and the post-thrombotic syndrome
|
|
|
1993
|
70 |
S1 |
p. S52-
1 p.
|
artikel
|
| 280 |
TAT and D-dimer levelsafter coronary angiography with a non-ionic contrast medium
|
|
|
1993
|
70 |
S1 |
p. S103-
1 p.
|
artikel
|
| 281 |
Teeth extractions in patients on long-term oral anticoagulant therapy without withdrawal of coumarins: Our experience
|
|
|
1993
|
70 |
S1 |
p. S26-
1 p.
|
artikel
|
| 282 |
The computer management improves the quality of oral anticoagulant therapy: Experience of a centre
|
|
|
1993
|
70 |
S1 |
p. S137-
1 p.
|
artikel
|
| 283 |
The diagnosis of recurrent proximal-vein thrombosis by compression ultrasound
|
|
|
1993
|
70 |
S1 |
p. S49-
1 p.
|
artikel
|
| 284 |
The effect of anticardiolipin antibodies lupus anticoagulant on the procoagulant activity of platelets and platelet microvesicles is dependent on β2-glycoprotein I
|
|
|
1993
|
70 |
S1 |
p. S67-
1 p.
|
artikel
|
| 285 |
The effects of cloricromene on ex-vivo platelet functions. A cross-over, double-blind study versus placebo
|
|
|
1993
|
70 |
S1 |
p. S30-
1 p.
|
artikel
|
| 286 |
The genetic defect of type i von willebrand disease “vicenza” is linked to the von willebrand factor gene
|
|
|
1993
|
70 |
S1 |
p. S99-
1 p.
|
artikel
|
| 287 |
The immunity system in patients treated with rFVIII: II. Appearance of alloantibodies against factor VIII
|
|
|
1993
|
70 |
S1 |
p. S166-
1 p.
|
artikel
|
| 288 |
The in vitro thromboxane A2 production by platelets of diabetic patients is normal at physiological [Ca2+]o
|
|
|
1993
|
70 |
S1 |
p. S27-
1 p.
|
artikel
|
| 289 |
The levels of prothrombin activation fragment (F1+2) in patients with prosthetic heart valves treated with chronic warfarin therapy
|
Buggiani, A.
|
|
1993
|
70 |
S1 |
p. S136-
1 p.
|
artikel
|
| 290 |
The prethrombotic state induced by anticancer drugs therapy in women with breast cancer
|
|
|
1993
|
70 |
S1 |
p. S148-
1 p.
|
artikel
|
| 291 |
The proaggregating cysteine proteinase of thrombotic thrombocytopenic purpura (TTP) is not Ca++-dependent
|
|
|
1993
|
70 |
S1 |
p. S95-
1 p.
|
artikel
|
| 292 |
Therapeutic doses of low molecular weight heparin previous to the standard prophylaxis for hip replacement: a pilot study
|
|
|
1993
|
70 |
S1 |
p. S13-
1 p.
|
artikel
|
| 293 |
The role of lipoprotein(a) in liver cirrhosis
|
|
|
1993
|
70 |
S1 |
p. S42-
1 p.
|
artikel
|
| 294 |
The TXA2 analogue, U-46619, inhibits PMN leukocyte function in vitro
|
|
|
1993
|
70 |
S1 |
p. S144-
1 p.
|
artikel
|
| 295 |
Thrombin-antithrombin complexes (TAT) and PAI-1 in patients undergoing total hip replacement and LMWH (CY 216) prophylaxis
|
|
|
1993
|
70 |
S1 |
p. S134-
1 p.
|
artikel
|
| 296 |
Thrombocytopenia in pregnancy: A single department experience
|
|
|
1993
|
70 |
S1 |
p. S114-
1 p.
|
artikel
|
| 297 |
Thrombolytic and fibrinolytic therapies: criteria for a differentation
|
Laghi Pasini, F.
|
|
1993
|
70 |
S1 |
p. S164-
1 p.
|
artikel
|
| 298 |
Thrombolytic and haemorrhagic effects of bolus doses of rt-PA and A hybrid plasminogen activator with prolonged plasma half-life (K2tu-PA: CGP 42935)
|
Iorio, A.
|
|
1993
|
70 |
S1 |
p. S91-
1 p.
|
artikel
|
| 299 |
Thrombolytic treatment in acute ischemic stroke
|
|
|
1993
|
70 |
S1 |
p. S7-
1 p.
|
artikel
|
| 300 |
Thrombosis and oral contraceptives: High frequency of abnormalities of natural inhibitors of coagulation
|
|
|
1993
|
70 |
S1 |
p. S36-
1 p.
|
artikel
|
| 301 |
Thrombosis and thrombocytopenia in antiphospholipid syndrome(idiopathic and secondary to sle): data from the italian registry on 319 cases
|
|
|
1993
|
70 |
S1 |
p. S82-
1 p.
|
artikel
|
| 302 |
Thrombosis-thrombocytophenia syndrome heparin induced (T.T.S.H.I.): Report of a case
|
|
|
1993
|
70 |
S1 |
p. S133-
1 p.
|
artikel
|
| 303 |
Thrombotic microangiopathy
|
Ruggenentl, Piero
|
|
1993
|
70 |
S1 |
p. S2-
1 p.
|
artikel
|
| 304 |
Thrombotic microangiopathy succesfully treated by iloprost: a report of six cases
|
|
|
1993
|
70 |
S1 |
p. S97-
1 p.
|
artikel
|
| 305 |
Thrombotic risk in thalassaemia major and intermedia
|
|
|
1993
|
70 |
S1 |
p. S130-
1 p.
|
artikel
|
| 306 |
Thrombotic thrombocytopenic purpura and large brain infarctions
|
|
|
1993
|
70 |
S1 |
p. S119-
1 p.
|
artikel
|
| 307 |
Thrombotic thrombocytopenic purpura: not only microcirculation may be involved
|
|
|
1993
|
70 |
S1 |
p. S118-
1 p.
|
artikel
|
| 308 |
Thrombotic thrombocytopenic purpura relapsing during pregnancy
|
|
|
1993
|
70 |
S1 |
p. S118-
1 p.
|
artikel
|
| 309 |
Thrombotic thrombocytopenic purpura (TTP) and hemolytic-uremic syndrome (HUS): binding of patients' von willebrand factor to platelet glycoprotein ib/ix
|
|
|
1993
|
70 |
S1 |
p. S96-
1 p.
|
artikel
|
| 310 |
Thromboxane biosynthesis in patients with systemic lupus erythematosus
|
Davi', G.
|
|
1993
|
70 |
S1 |
p. S69-
1 p.
|
artikel
|
| 311 |
Tissue-pathway inhibitor and tumor necrosis factor in septicemia
|
|
|
1993
|
70 |
S1 |
p. S44-
1 p.
|
artikel
|
| 312 |
Tissue-type plasminogen activator and plasminogen activator inhibitor in raynaud's phenomenon
|
Silveri, F.
|
|
1993
|
70 |
S1 |
p. S93-
1 p.
|
artikel
|
| 313 |
Treatment of obliterative arteriopathy of the lower limbs using intrarterially administered defibrotide
|
|
|
1993
|
70 |
S1 |
p. S139-
1 p.
|
artikel
|
| 314 |
Tumor necrosis factor and endothelial function in patients with macro and microcrovascular involvement
|
Cimminiello, C.
|
|
1993
|
70 |
S1 |
p. S104-
1 p.
|
artikel
|
| 315 |
Two cases of acute coronary thrombosis with anti-platelets IGM and antiphospholipids antibodies
|
Marchetti, G.
|
|
1993
|
70 |
S1 |
p. S115-
1 p.
|
artikel
|
| 316 |
Two different enzyme-immunosorbent assays based upon monoclonal antibodies of human FVII
|
|
|
1993
|
70 |
S1 |
p. S57-
1 p.
|
artikel
|
| 317 |
Type II C antithrombin III (at III) defect and cerebral arterial thrombosis: a case report
|
|
|
1993
|
70 |
S1 |
p. S108-
1 p.
|
artikel
|
| 318 |
Type I “platelet low” von willebrand disease: decreased platelet adhesion and low synthesis of von willebrand factor in endothelial cells
|
|
|
1993
|
70 |
S1 |
p. S98-
1 p.
|
artikel
|
| 319 |
Unfractionated heparin and low molecular weight heparins (LMWH) effects on bleeding time and anti-Xa activity in healthy volunteers
|
|
|
1993
|
70 |
S1 |
p. S17-
1 p.
|
artikel
|
| 320 |
Unfractionated heparin modifies clot structure and increases clot sensitivity to t-PA-induced lysis
|
|
|
1993
|
70 |
S1 |
p. S15-
1 p.
|
artikel
|
| 321 |
Upper-extremity deep venous thrombosis: Study of an outpatient population
|
|
|
1993
|
70 |
S1 |
p. S132-
1 p.
|
artikel
|
| 322 |
Uremic patients have normal plasma and platelet von willebrand factor structure, regardless of bleeding time
|
|
|
1993
|
70 |
S1 |
p. S101-
1 p.
|
artikel
|
| 323 |
Use of oral contraceptives is a major risk factor for venous thromboembolism and cerebral ischemia in young women
|
|
|
1993
|
70 |
S1 |
p. S37-
1 p.
|
artikel
|
| 324 |
Use of protein c concentrate during open heart surgery: a case report
|
Rossi, E.
|
|
1993
|
70 |
S1 |
p. S109-
1 p.
|
artikel
|
| 325 |
Vascular fibrinolysis in aging: enhanced response to adrenergic stimulation
|
Iacoviello, Licia
|
|
1993
|
70 |
S1 |
p. S77-
1 p.
|
artikel
|
| 326 |
von Willebrand disease and von Willebrand factor
|
|
|
1993
|
70 |
S1 |
p. S7-
1 p.
|
artikel
|
Tijdschrift beschrijving